Objectives-To evaluate the diagnostic performance of Virtual Touch tissue imaging quantification (VTIQ; Siemens Medical Solutions, Mountain View, CA) in combination with the Thyroid Imaging Reporting and Data System (TI-RADS) for assessing thyroid nodules referred for biopsy.
W
ith the widespread use of high-frequency ultrasound (US) for the detection of thyroid nodules, up to 67% of adults have a diagnosis of thyroid nodules, 1 whereas only 5% to 15% of them are malignant. 2 Several US features, such as echogenicity, margin, calcifications, and shape, can be used to discriminate benign from malignant nodules. [3] [4] [5] By applying these US features, several USbased versions of the Thyroid Imaging Reporting and Data System (TI-RADS) have been developed for risk stratification of thyroid nodules. 6, 7 Different categories with different risks of malignant possibility are established by the TI-RADS, which is derived from the American College of Radiology Breast Imaging Reporting and Data System. Kwak et al 8 recently proposed a relatively simple TI-RADS, which includes 5 suspicious US features: a solid composition, hypoechogenicity or marked hypoechogenicity, a microlobulated or irregular margin, microcalcifications or mixed calcifications, and a taller-than-wide shape. Thyroid Imaging Reporting and Data System category 4 nodules usually should be referred for fine-needle aspiration (FNA) biopsy to confirm or exclude the diagnosis of malignancy; however, the spectrum of malignancy rates (3.3%-72.4%) is broad for category 4 nodules. 8 It is necessary to find some complementary examinations to further stratify TI-RADS category 4 nodules.
Ultrasound elastography is a method that can measure the stiffness of tissue, which consists of strain elastography and shear wave elastography (SWE). 9 Previous studies have showed that strain elastography has the potential for differentiating between benign and malignant thyroid nodules, whereas its sensitivity and specificity varied from 73% to 100% and 50% to 96% respectively. [10] [11] [12] [13] [14] [15] Strain elastography is usually qualitative or semiquantitative and is generated by manual compression, which is dependent on the experience of the operator and thus is less reproducible. Shear wave elastography is a quantitative elastographic technology for transverse shear wave velocity (SWV) measurement and imaging using acoustic radiation force impulse excitation, which includes point SWE and 2-dimensional (2D) SWE. Virtual Touch tissue quantification (VTQ; Siemens Medical Solutions, Mountain View, CA) is a type of point SWE with a fixed 5 3 6-mm sample region of interest (ROI) for SWV measurement. Several recent studies have shown that VTQ is useful for differentiation between benign and malignant thyroid nodules by quantitative stiffness measurement. [16] [17] [18] However, one of its inadequacies is that the visual stiffness distribution in the nodule is not available; thus, the stiffest region or the region without shear wave propagation in the nodule is unknown, which may lead to inappropriate ROI placement in the nodule and then result in an invalid SWV measurement. As an update of the point SWE technique, Virtual Touch tissue imaging quantification (VTIQ; Siemens Medical Solutions) is a 2D quantitative SWE technology that has the ability to synthesize information from up to 256 sequential acquisition beam lines inside a 2D color-coded shear wave image and measure localized quantitative SWV values with a wider measurement range (0.5-10 m/s in VTIQ versus 0.5-8.4 m/s in VTQ) and smaller shear wave ROIs (smallest, 1.5 3 1.5 mm in VTIQ versus 5 3 6 mm in VTQ). In addition, unlike SuperSonic imaging (Aixplorer; SuperSonic Imagine; Aix-en-Provence, France), another type of 2D SWE, VTIQ provides a unique 2D color-coded shear wave quality mode, which can intuitively show whether the shear wave has a sufficient magnitude and signal-to-noise ratio for precise SWV measurement, which is meaningful for avoiding an invalid SWV measurement.
Until recently, although VTIQ has been used in various organs such as the breast, testicle, and lymph node, [19] [20] [21] its use in the thyroid was only documented in 1 study by Azizi et al. 22 In their study, Azizi et al 22 concluded that thyroid nodule stiffness measured by VTIQ-generated SWE was an independent predictor of thyroid malignancy. However, to our knowledge, no study had been conducted to evaluate the usefulness of combined VTIQ and TI-RADS yet. We hypothesized that the application of VTIQ singly or added to the US TI-RADS would improve the diagnostic performance for thyroid nodules referred for biopsy. The purpose of our study was to retrospectively evaluate the use of VTIQ alone and in conjunction with the TI-RADS criteria for assessing thyroid nodules in this population.
Materials and Methods

Patients
This retrospective study was approved by our Institutional Review Board, and informed consent was obtained from all patients. From January 2015 to August 2015, we examined 1100 consecutive patients by conventional US and VTIQ imaging in a tertiary hospital. All patients were enrolled for the following reasons: (1) thyroid nodules were detected by conventional US in a secondary or junior clinic; (2) thyroid nodules were palpable by clinicians; and (3) discomfort or compression symptoms appeared in the cervical region. When the patients had multiple nodules, we selected the nodules with the most suspicious US features for analysis (ie, solid, marked hypoechogenicity, microlobulated or irregular margins, microcalcifications, or taller-than-wide shape). 8 When no nodule was suspicious, the largest one was selected. In total, 1233 thyroid nodules were observed. Patients were excluded as follows: (1) 534 patients with 616 nodules refused recommended FNA and surgery; thus, neither pathologic nor cytological results were available; (2) 162 nodules in 151 patients had inconclusive diagnoses of cytologic findings based on the Bethesda system after FNA (ie, nondiagnostic or unsatisfactory, atypia of undetermined significance or follicular lesion of undetermined significance, follicular neoplasm or suspicion of follicular neoplasm, or suspicion of malignancy) 23 but did not undergo surgery; (3) 54 nodules in 49 patients were diagnosed as benign by cytologic analysis but lost at follow-up; and (4) 204 nodules in 179 patients were less than 1 cm in diameter on US imaging (according to the size criteria of the TI-RADS of Kwak et al 8 , since thyroid malignancy of less than 1.0 cm has been regarded as insignificant in recent years. 24, 25 Ultimately, 197 nodules in 187 patients were enrolled in the study (Figure 1 ). In 177 patients, only 1 nodule was evaluated, and in the remaining 10 patients, 2 nodules were evaluated in each patient.
Ultrasound and VTIQ Examinations
Conventional US and VTIQ examinations were performed with the same Siemens S3000 US scanner.
Conventional US examinations were performed by using a 5-14-MHz linear array transducer and VTIQ by using a 4-9-MHz linear array transducer. Both examinations were performed on the same date by the same operator, a board-certified physician with more than 2 years of experience in thyroid US and more than 1 year in thyroid elastography. First, conventional US imaging was performed, and each target nodule was observed in transverse and longitudinal US images. Then the images were stored by following the protocol for further assessment.
Virtual Touch tissue imaging quantification elastography was subsequently performed before FNA biopsy. The target nodule was placed in the center of the screen on longitudinal US images. While the shear wave image was generated, patients were required not to breathe or swallow for a few seconds. The VTIQ shear wave quality mode was first applied, in which different colors are shown to indicate shear wave quality, with green for high quality, yellow for intermediate quality, and red for low quality. In the VTIQ SWV mode, a 2D shear wave map is generated and the information on the SWV distribution is coded in different colors such that red, green, and blue indicate the highest, intermediate, and lowest SWVs, respectively. In this mode, a square shear wave ROI of approximately 1.5 3 1.5 mm was placed on the site corresponding to the green region in the shear wave quality mode, which ensures a valid SWV measurement. Meanwhile, cystic or large calcifications in the nodule were avoid for ROI placement. Generally, 5 to 7 shear wave ROIs were located in the nodule. When the nodule showed a homogeneous stiffness distribution in on the 2D VTIQ SWV map, ROIs were placed randomly. When the nodule showed a heterogeneous stiffness distribution, 2 shear wave ROIs were placed on the highest and lowest stiffness areas, respectively, whereas the rest of the shear wave ROIs were placed randomly in the nodule. Then the surrounding tissue was dealt with likewise. All data were recorded for further analysis (Figures 2 and 3 ).
Image Interpretation
On US images, the nodule was evaluated for position (left lobe, right lobe, or isthmus), size (largest diameter), composition (completely solid nodules, predominantly solid nodules with cystic portions of <50%, or predominantly cystic nodules with cystic portions of >50%), echogenicity (hyperechoic, isoechoic, or hypoechoic to Figure 2 . Images from a 51-year-old woman with a nodular goiter. A, On conventional US imaging, a 20-mm nodule in the left lobe of the thyroid (arrows) shows predominantly solid, hypoechoic, well-circumscribed features. B, Virtual Touch tissue imaging quantification shear wave quality mode shows high-quality generated shear waves in the nodule. C, Virtual Touch tissue imaging quantification SWV mode shows the nodule with a mean SWV value (Vs) of 2.61m/s, ranging from 2.35 to 3.00m/s. D, Histologic specimen shows that this thyroid nodule was finally confirmed as a nodular goiter (hematoxylin-eosin, original magnification 3 400). The nodule was classified as TI-RADS category 4a with conventional US, whereas it was downgraded to category 3 with the combined method.
surrounding thyroid tissue, regardless of abnormal surrounding thyroid tissue echogenicity, or markedly hypoechoic if the echogenicity was lower than the adjacent strap muscle), margin (well or poorly circumscribed, with poorly circumscribed including a microlobulated or an irregular margin), calcifications (microcalcifications or mixed calcifications, macrocalcifications or eggshell calcifications, and no calcifications, with microcalcifications defined as <1 mm in diameter), and shape (taller than wide or not; Figure 4 ). Suspicious US features were defined as solid, hypoechogenicity or marked hypoechogenicity, a microlobulated or an irregular margin, microcalcifications or mixed calcifications, and a tallerthan-wide shape. 8 The nodules with no suspicious US features were classified as TI-RADS category 3, whereas those with 1, 2, 3, and 4 or 5 suspicious US features were classified as TI-RADS categories 4a, 4b, 4c, and 5, respectively ( Figure 4) . 8 Both US images and TI-RADS categories were analyzed and recorded by 2 boardcertified thyroid physicians independently, each with more than 5 years of experience in thyroid US. The identification of the patients was not available to them. They were also blinded to image acquisition, VTIQ assessment, and cytologic/pathologic results. When Figure 3 . Images from a 39-year-old woman with papillary carcinoma. A, On conventional US imaging, a 14-mm nodule in the right lobe of the thyroid (arrows) shows solid, hypoechoic, poorly circumscribed, taller-than-wide features with microcalcifications. B, Virtual Touch tissue imaging quantification shear wave quality mode shows high-quality generated shear waves in the nodule. C, Virtual Touch tissue imaging quantification SWV mode shows the nodule with a mean SWV value (Vs) of 3.79 m/s, ranging from 3.07 to 4.82 m/s. D, Histologic specimen shows that this thyroid nodule was finally confirmed as a papillary carcinoma (hematoxylin-eosin, original magnification 3 400). The nodule was classified as TI-RADS category 5 category, and the mean SWV value was also higher than 2.90 m/s.
there was a disagreement between the investigators, a third investigator with 20 years of experience in thyroid US checked the images and made the conclusive decision.
Four VTIQ measurements were calculated and recorded by an investigator: another physician blinded to image acquisition, US assessment, and cytologic/pathologic results: (1) SWV mean , mean SWV value of the nodule; (2) SWV max , maximum SWV value of the nodule; (3) SWV min , minimum SWV value of the nodule; and (4) SWV ratio , ratio between SWV mean and the mean SWV value of the surrounding tissue.
Ultrasound-Guided FNA Ultrasound-guided FNA was applied to the target thyroid nodule by using a 22-gauge needle attached to a 5-mL syringe. Local anesthesia was performed routinely by using 3 to 5 mL of 1% lidocaine. Aspirated material was expelled onto glass slides and smeared. Then the glass slides were placed in 95% ethanol immediately. The samples were submitted for cytologic evaluation based on the Bethesda System for Reporting Thyroid Cytopathology. 23 One of 3 board-certified cytopathologists, each with more than 5 years of experience in thyroid pathology, interpreted the cytologic slides. All of them were blinded to the US and VTIQ results.
Surgical Intervention and Histopathologic Assessment
Unilateral thyroid lobectomy or total thyroidectomy was performed by the surgeons of our hospital. Lymph node excision was also performed if necessary. The histologic specimens were then assessed according to World Health Organization criteria. 26 
Data and Statistical Analyses
Cytologic results from FNA and histologic results from surgery were considered the standards of reference. Nodules diagnosed as malignant by FNA without surgery were considered malignant, since the patients were recommended for surgery but chose other hospitals for surgery. Nodules diagnosed as benign by FNA and followed at least 6 months without growth in size at US were considered benign (growth was defined as a 20% increase in nodule diameter with a minimal increase of 2 mm in at least 2 dimensions or a > 50% change in volume). 27 Continuous variables were checked for normality by the Shapiro-Wilk test and for homogeneity of variances by the Levene test. A comparison of continuous variables with benign and malignant nodules was performed by an independent t test, whereas the v 2 test was performed for categorical variables. A receiver operator characteristic curve analysis was performed to evaluate the diagnostic performance. The areas under the curves (AUCs) were computed to assess the diagnostic performances of different SWV parameters, and the z test was used to compare the AUC. The cutoff value was obtained when the Youden index (sensitivity 1 specificity -1) achieved its maximum. Paired comparisons of sensitivity and specificity were evaluated by the McNemar test. Significance was assigned at 2-tailed P < .05. All statistical analyses were performed with SPSS version 20.0 software (IBM Corporation, Armonk, NY).
Results
Pathologic Diagnosis
The 187 patients included 137 women and 50 men with a mean age 6 SD of 49 6 14 years (range, 17-77 years). The mean nodule size was 19.1 6 10.2 mm (range, 10-63 mm). Of the 197 thyroid nodules, 134 were benign, and 63 were malignant. Sixty-six benign and 44 malignant nodules were confirmed by surgery; 19 malignant nodules were confirmed by cytologic assessment; and 68 nodules were diagnosed as benign by cytologic assessment, and none of them grew in follow-up; thus, they were considered benign (Figure 1 ). The median followup interval from the initial US-guided FNA to the last follow-up US in nodules diagnosed as benign by FNA but without surgery was 12 months (range, 6-16 months). The pathologic diagnoses of the 110 nodules that underwent surgery are listed in Table 1 . Table 2 lists the summary of demographic and US features. Patient age and sex did not significantly differ between malignant and benign groups (P 5 .205 and .230, respectively). The size of benign nodules was significantly larger than that of malignant ones (P < .05). Ultrasound features, such as a solid component, marked hypoechogenicity, microlobulated or irregular margins, microcalcifications or mixed calcifications, and a tallerthan-wide shape were more frequently found in malignant nodules than in benign ones (all P < .001).
Comparisons Between Basic and Pathologic Characteristics
Diagnostic Performance of the TI-RADS, VTIQ, and Their Combination
The distribution of lesions in each US TI-RADS category is listed in Table 3 . The malignant rates of TI-RADS categories 3, 4a, 4b, 4c, and 5 were 3.6% (1 of 28), 8.5% (4 of 47), 11.1% (6 of 54), 72.7% (40 of 55) and 92.3% (12 of 13), respectively. When considering category 3 as benign and categories 4a to 5 as malignant, the AUC of the TI-RADS was 0.593 6 0.041 (95% confidence interval, 0.512-0.673), with 98.4% (62 of 63) for sensitivity and 20.1% (27 of 134) for specificity ( Figure 5B ).
The comparisons between the benign and malignant thyroid nodules by VTIQ are shown in Table 4 . All 4 VTIQ measurements of malignant nodules were significantly higher than those of benign nodules (all P < .001). The optimal cutoff values for the SWV mean , SWV max , SWV min , and SWV ratio were 2.90 m/s, 3.28 m/s, 2.46 m/s, and 1.15, respectively, and the AUCs for them were 0.818, 0.805, 0.799, and 0.728. Among them, the AUC of the SWV mean was slightly higher than that of the SWV max and SWV min (both P > .05) and significantly higher than that of the SWV ratio (P 5 .017). With a cutoff value of 2.90 m/s, the sensitivity and specificity of the SWV mean were 71.4% and 82.8% ( Figure 5A ).
By applying an SWV mean value of 2.90 m/s or less as a standard for downgrading category 4a lesions to category 3, 83.7% (36 of 43) of benign category 4a lesions were successfully downgraded to category 3 (Table 3 and Figure 2 ). The specificity significantly rose from Figure 5b ). Ultimately, with the combination of TI-RADS and VTIQ, there were 7 benign lesions left in category 4a, including benign lesions confirmed by FNA (n 5 3), nodular goiters (n 5 3), and a Hashimoto nodule associated with Hashimoto thyroiditis (n 5 1). There was only 1 malignant lesion in category 3, and its final pathologic result was follicular carcinoma with tiny infiltration after surgery.
Discussion
Due to the increase in detection of thyroid nodules with US, the numbers of thyroid FNAs and thyroid cancers have greatly increased. 28, 29 To facilitate communication and reduce confusion among physicians and patients, an applicable standard is necessary. In 2009, Horvath et al 6 and Park et al 7 proposed different versions of the TI-RADS to stratify the malignancy risk of thyroid nodules with US imaging. However, the TI-RADS is complicated and involves many US features; thus, it is not easy to apply in daily practice. 8, 30 In this study, a relatively convenient TI-RADS suggested by Kwak et al 8 was used, which was based on both malignant risk and fitted probability. In this TI-RADS, 8 5 suspicious US features were applied for malignancy risk stratification, and all showed significant differences between benign and malignant nodules, which was also proved in our study. Moreover, in the TI-RADS, category 3 is defined as probably benign, and categories 4a to 5 are defined as suspicious for malignancy from low to high; hence we considered category 3 as benign and categories 4a to 5 as malignant. Accordingly, this TI-RADS achieved high sensitivity of 98.4% but low specificity of 20.1% in our study current study. Yoon et al 31 also reported sensitivity of 97.4% and specificity of 29.3% by applying this TI-RADS, which were similar to our results. Low specificity was associated with an increasing number of false-positive nodules (n 5 71) by this method, which meant many unnecessary FNAs.
To supplementarily select nodules for FNA biopsy, an up-to-date 2D SWE technology, VTIQ, was applied in this study. To date, only 1 study reported the application of VTIQ for evaluating thyroid nodules, 22 although VTIQ has been shown to be useful and reproducible in accessing breast lesions and other organs. 19, 20, 32, 33 In this study, the SWV parameters in malignant nodules were all higher than those in benign nodules, and the SWV mean showed the highest AUC value among them, with a cutoff value of 2.90 m/s. By comparison, in a previous study, Azizi et al 22 reported that VTIQ showed an AUC of 0.78 with a cutoff value of 3.54 m/s. The SWV Figure 5 . Receiver operating characteristic curves for VTIQ measurements (A) and TI-RADS alone and VTIQ combined with TI-RADS (B). was higher than that in our study because the measurement was located in the stiffest region of the nodule in their study, which was similar to the results for the SWV max in our study. With the use of other 2D SWE techniques such as SuperSonic imaging, AUC values from 0.795 to 0.840 were obtained, which demonstrated that VTIQ had similar diagnostic performance in comparison with other 2D SWE techniques. [34] [35] [36] The cutoff SWV value for all thyroid nodules in this study was slightly higher than those in other studies using a point SWE technique such as VTQ, [16] [17] [18] 37, 38 which had a range of 2.50 to 2.87 m/s. This disagreement may have been due to the differences in ROI placement for SWV measurements. Virtual Touch tissue imaging quantification facilitates visualization of the shear wave distribution in a 2D map; thus, the shear wave ROIs can be placed correctly in the appropriate sites. In addition, VTIQ provides a shear wave quality map; thus, shear wave ROI placement in unwanted areas without shear wave propagation is avoided. However, for VTQ, the shear wave ROI is fixed at 5 3 6 mm, which in fact obtains the mean SWV in the box, although it is not site specific. In addition, many invalid measurement results such as X.XX m/s are encountered, so they have to be discarded or replaced by 0 or 8.4 m/s according to operator experience, which might greatly influence the final measurement results. 17 After the combination of TI-RADS and VTIQ, the specificity significantly rose to 47.0% and the sensitivity remained at 98.4% in this study. Park et al 39 reported similar results as ours, with sensitivities that ranged from 94.7% to 95.5% and specificities that ranged from 34.4% to 56.7% by application of a combination another 2D SWE technique (SuperSonic imaging) to conventional US. Liu et al 36 reported that by applying a cutoff Young modulus value of 39.3 kPa, the combination of SuperSonic imaging with conventional US achieved higher specificity of 73.9% but lower sensitivity of 87.1% than our results. As the aim of our study was to assess thyroid nodules referred for biopsy, higher sensitivity was the first condition, which meant fewer missed detections of malignant lesions. On this basis, how to avoid unnecessary FNA of benign nodules would be taken into account.
With the application of a SWV mean cutoff value of 2.90 m/s, all nodules that were downgraded from category 4a to category 3 were benign on the final pathologic analysis. Additionally, by with the application of this criterion, 36 of 43 benign category 4a lesions could avoid unnecessary US-guided FNA. Finally, there were 7 false-positive lesions in category 4a and 1 false-negative lesion in category 3 for the combination method. In all of the false-positive results, higher SWVs than the cutoff value were found, which might be explained as follows: (1) a nodular goiter with local fibrosis; (2) a lesion with a depth of greater than 4 cm or a lesion located in isthmus; and (3) Hashimoto thyroiditis leading to fibrosis of the thyroid gland. 22 The false-negative lesion with a lower SWV had a final pathologic result of follicular carcinoma with tiny infiltration after surgery. This finding may have been due to fact that the gross anatomy and cellular patterns of follicular carcinoma overlap with those of benign follicular adenoma. In general, follicular carcinoma can be discriminated from benign follicular adenoma only by the presence of capsular or vascular invasion, which requires a histologic examination, and sometimes even such an examination cannot give the right answer. 12 There were several limitations in our study. First, as sensitivity was prioritized in the study, the combination method achieved high sensitivity of 98.4% but relatively low specificity of 47.0%. Hence a better combination method may be recommended in the future. Second, most of the patients with benign FNA results did not undergo surgery for a definite diagnosis. In spite of benign biopsy results with at least a 6-month follow-up, the possibility of malignancy may still have existed. Therefore, this study may have been biased by unrecognized papillary carcinomas among apparently benign nodules without growth. However, it has been reported that the false-negative rate for cytologic biopsy is less than 3% to 5.8%. 23, 40 Third, conventional US and VTIQ examinations were performed by the same operator. This factor may have led to an operator-related selection bias. Fourth, retrospective convenience sampling was used in this study, which recruited patients who were examined by conventional US and VTIQ imaging. This limitation meant that many potential patients would have been excluded by that criterion. Thus, we recommend prospective studies, in which the patient population number is based on an estimate of statistical power to prove our results. Finally, the TI-RADS suggested by Kwak et al 8 was used in this study; nevertheless, until now, no TI-RADS has been widely accepted or recommended by any guidelines.
In conclusion, VTIQ is a useful method for differentiating malignant from benign thyroid nodules. It can improve the specificity of the TI-RADS for evaluating thyroid nodules without a loss of sensitivity. As the application of the US TI-RADS for evaluating thyroid nodules may ensure that most malignant nodules can be selected for biopsy or surgery, adding VTIQ can avoid unnecessary FNA in some benign nodules, which can be followed safely.
